NDAORALTABLET
Approved
May 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
IBU (ibuprofen) by Design Pharmaceuticals is cyclooxygenase inhibitors [moa]. First approved in 1981.
Drug data last refreshed 1h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Ibuprofen is a cyclooxygenase inhibitor oral tablet approved in 1981 for anti-inflammatory and analgesic indications. It is a small-molecule NSAID widely used for pain relief, fever reduction, and inflammation management across diverse patient populations. The drug works by inhibiting COX enzymes to reduce prostaglandin synthesis.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), signaling potential team restructuring and transition focus toward generic/OTC management.
Mechanism of Action
Cyclooxygenase Inhibitors
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead
Started Nov 2026
59 enrolled
KeratosisActinic Keratoses
Phase I Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Solid Tumors Like GBM and PDAC
Started Aug 2026
20 enrolled
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Magnetic Ressonance Imaging of Temporomandibular Joint
Started Aug 2026
Effects of Vagus Nerve Stimulation on Temporomandibular Disorders.
Started Aug 2026
10 enrolled
TMDTemporomandibular Disorders (TMDs)
A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants
Started Jul 2026
84 enrolled
Ebola-Bundibugyo Virus Disease (Ebola-BDBV)
Worked on IBU at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.